Investor Relations excellent, which is rare on the VentureExcellent job by the IR staff at EAST.v to clarify and quash this before it gets added to the bashers' tool box. Remember, the people spreading this sort of stuff are almost always trying to scare your shares into their hands.
Here is my motivation, plain and simple: I own 179,000 shares at .14c and I would like to at least double my money.
Very pleaseD with how this is all going, and really happy that they hired a good IR person.
QUOTE:
"
Hi, This is Nicholas at EAST IR. I monitor these boards but normally do not participate to avoid potential bias in the threads. On this topic however, I would offer my email response sent earlier this morning: Thank you for making the effort to seek clarification on this article.
The article is written in a way the puts Rodney at the centre, when in fact Rodney was not with Graydon Elliot when it was shut down, he had earlier resigned. Pertinent facts of the case are:
- Rodney was not with Graydon as manager or owner when it was shut down.
- Rodney was cleared by the BCSC in 2009 after their extensive research into Graydon Elliot's cash flow problems and subsequent shutdown.
- Rodney was again extensively researched with extra due diligence by the TSX and OSC in 2018 prior your becoming the CEO and director of EastWest Bioscience, a publicly listed and trading company.
Should you wish to read the entire IDA decision it is publicly available.
I and my fellow team members have every confidence in Rodney's integrity and are proud to be building a first class company in the emerging CBD space.
Again, thank you for taking the time to seek clarity on this issue and thank you for your investment and interest in EAST.
Read more at https://stockhouse.com/companies/bullboard?symbol=v.east&postid=29479164#xWyMTwsJFQl6Pr92.99"
-UNQUOTE